Advertisement

Topics

CORRECTING and REPLACING -- Celsion Files Immunotherapy Clinical Protocol for the Evaluation of ...

14:23 EST 13 Nov 2017 | BioMedReports - Blog

 Expert Advisory Board Endorses Randomized Phase I/II Trial in Newly Diagnosed 
Stage III and IV Ovarian Cancer

GEN-1 Immunotherapy to Enter Phase I/II Clinical Study in the First Half of 2018
Following a Phase IB Trial Demonstrating 100% Disease Control, 86% Objective Response Rate
and 86% R0 & R1 Surgical Resection Rate in All Patients Treated

LAWRENCEVILLE, N.J., Nov. 13, 2017 (GLOBE NEWSWIRE)

Read more...

Original Article: CORRECTING and REPLACING -- Celsion Files Immunotherapy Clinical Protocol for the Evaluation of ...

NEXT ARTICLE

More From BioPortfolio on "CORRECTING and REPLACING -- Celsion Files Immunotherapy Clinical Protocol for the Evaluation of ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...